Confirm current status directly through the LegitScript certificate lookup - do not rely on the badge displayed on the brand's website alone
Having a sharps disposal container ready
Side effect profile and personal tolerance should guide timing decisions
Disclosures: Edward Gane: Nothing to Disclose, Tawesak Tanwandee: Roche: Grant/Research Support, MSD: Grant/Research Support, Altimune: Grant/Research Support, Gilead: Grant/Research Support, Vir Biotech: Grant/Research Support, Bitna Yi: Gilead Sciences, Inc.: Employee, Teri Chew: Gilead Sciences, Inc: Employee, Irina Botros: Nothing to Disclose, Danielle Shing: Nothing to Disclose, Heba Abdullah: Nothing to Disclose, Leonard Sowah: GILEAD Sciences, Inc: Employee, Frida Abramov: Gilead Sciences, Inc: Employee, Gilead Sciences, Inc: Stock - publicly traded company, Ben Da: Nothing to Disclose, Audrey Lau: Nothing to Disclose, Anu Osinusi: Nothing to Disclose, Tak Yin Owen Tsang: Nothing to Disclose, Anchalee Avihingsanon: Nothing to Disclose 368 DETECTION AND MONITORING OF INFANT DRUG EXPOSURE: A STUDY ON TFV CONCENTRATION IN TDF AND TAF Chengjing Tao Background: A few studies have observed the Tenofovir (TFV) concentration of Tenofovir Disoproxil Fumara (TDF) and Tenofovir Alafenamide Fumarate (TAF) in the blood, milk, and amniotic fluid of pregnant women, but few have investigated the concentration of TFV in infant blood and urine, which could aid in detecting and monitoring infant drug exposure
Outcomes The primary outcome was the measurement of total testosterone levels before and after GLP-1 RAs administration, chosen for its strong association with the clinical manifestations of hypogonadism in men
Testing fasting insulin is a scientifically validated tool that's not routinely used in clinical medicine but it allows us to predict pre-diabetes or insulin resistance up to 15 years before we see an increase in average blood sugar markers
